📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Insmed

1.1 - Company Overview

Insmed Logo

Insmed

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical medicines for rare diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Insmed

Stat-Dx Logo

Stat-Dx

HQ: Spain Website
  • Description: Provider of near-patient testing products for healthcare professionals, primarily for short turnaround time applications and critical care.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Stat-Dx company profile →
AiCuris Logo

AiCuris

HQ: Germany Website
  • Description: Provider of resistance breaking antiviral and antibacterial therapeutics targeting CMV, HSV, HIV, hepatitis B and C, and multi-resistant bacteria; offerings include PREVYMIS for CMV prevention in adult CMV-seropositive allogeneic stem cell or kidney transplant recipients, pritelivir (phase 3) for acyclovir-resistant HSV, AIC468 (preclinical) for BK virus, adenovirus treatment programs, and the AiCubator for early-stage research on viral infections in immunocompromised patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AiCuris company profile →
Infant Bacterial Therapeutics Logo

Infant Bacterial Therapeutics

HQ: Sweden Website
  • Description: Provider of clinical-stage pharmaceutical drug development focused on influencing the infant microbiome to prevent or treat rare diseases in infants. Developing IBP-9414 to prevent NEC in premature infants; IBP-9414 contains the active substance Lactobacillus reuteri, a human bacterial strain.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Infant Bacterial Therapeutics company profile →
Stat-Sure Diagnostics Logo

Stat-Sure Diagnostics

HQ: United States Website
  • Description: Provider of diagnostic testing specializing in HIV.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Stat-Sure Diagnostics company profile →
Revelation Biosciences Logo

Revelation Biosciences

HQ: United States Website
  • Description: Provider of immunologic therapeutics and diagnostics, including Gemini, a proprietary PHAD formulation for systemic administration for prevention of post-surgical infection, acute kidney injury, and chronic kidney disease; GEM-AKI and GEM-CKD therapies that redirect the innate immune response; and GEM-SSI for prevention or treatment of healthcare-associated bacterial infections (post-surgical/post-burn, UTIs, sepsis, antibiotic-resistant).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Revelation Biosciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Insmed

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Insmed

2.2 - Growth funds investing in similar companies to Insmed

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Insmed

4.2 - Public trading comparable groups for Insmed

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Insmed

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Insmed

What does Insmed do?

Insmed is a provider of biopharmaceutical medicines for rare diseases.

Who are Insmed's competitors?

Insmed's competitors and similar companies include Stat-Dx, AiCuris, Infant Bacterial Therapeutics, Stat-Sure Diagnostics, and Revelation Biosciences.

Where is Insmed headquartered?

Insmed is headquartered in United States.

How many employees does Insmed have?

Insmed has 1,000 employees 🔒.

When was Insmed founded?

Insmed was founded in 2010 🔒.

What sector and industry vertical is Insmed in?

Insmed is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Insmed

Who are the top strategic acquirers in Insmed's sector and industry

Top strategic M&A buyers and acquirers in Insmed's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Insmed?

Top strategic M&A buyers groups and sectors for Insmed include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Insmed's sector and industry vertical

Which are the top PE firms investing in Insmed's sector and industry vertical?

Top PE firms investing in Insmed's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Insmed's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Insmed's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Insmed's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Insmed include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Insmed's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Insmed?

The key public trading comparables and valuation benchmarks for Insmed include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Insmed for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Insmed with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Insmed's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Insmed with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Insmed's' sector and industry vertical?

Access recent funding rounds and capital raises in Insmed's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Insmed